Arcadia Biosciences Balance Sheet - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$9.98 $0.22 (2.16%) RKDA stock closing price May 25, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Arcadia Biosciences balance sheet. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Arcadia Biosciences stock analysis. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. The Arcadia Biosciences balance sheet for 2018 Q1 shows total assets of $22.6M. The company has a asset turnover ratio of 0.04. Also see: Arcadia Biosciences revenue and Arcadia Biosciences operating cash flow for the same quarter.

View and download Arcadia Biosciences quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Cash20.42M9.12M2.93M13.43M7.55M2.01M10.47M27.36M29.54M23.97M
Marketable Securities-3.89M12.76M30.74M40.96M48.54M43.41M26.87M20.65M26.27M
Receivables-1.23M--------
Inventory----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets--1.09M1.48M1.28M-1.18M1.39M1.33M-
Total Current Assets
21.25M15.04M17.16M46.51M50.44M52.22M55.67M56.19M52.53M52.01M
Property Plant & Equipment-5.18M---5.44M---5.24M
Accumulated Depreciation-4.88M---4.94M---4.65M
Net Property Plant & Equipment
----------
Investment & Advances-----2.49M3.47M6.91M14.9M19.74M
Other Non-Current Assets1.07M1.16M1.17M1.15M1.27M1.32M1.83M1.87M1.83M1.86M
Deferred Charges----------
Intangibles----------
Deposits & Other Assets----------
Total Assets
22.6M16.57M18.97M48.43M52.64M56.57M61.58M65.7M70.1M74.24M
Notes Payable---5.6M4.56M-----
Accounts Payable2.46M2.49M1.86M1.83M2.18M2.35M2.61M2.57M2.79M2.42M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities-1.02M----1.21M1.5M1.36M1.02M
Total Current Liabilities
3.03M3.52M2.52M6.69M5.17M3.12M3.82M4.07M4.15M3.45M
Mortgages----------
Deferred Taxes/Income-2.03M2.79M2.92M3.01M3.12M2.17M2.31M2.49M2.63M
Convertible Debt----------
Long-Term Debt---21.05M23.09M25.12M25.07M25.02M24.97M24.93M
Non-Current Capital Leases----------
Other Long-Term Liabilities18.9M3M3M3M3M3M3M3M3M3M
Total Liabilities
21.93M8.56M8.31M33.67M34.27M34.37M34.07M34.42M34.62M34.01M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus176.13M175.22M174.92M174.5M174.11M173.72M173.31M172.91M172.58M172.22M
Retained Earnings-175.5M-167.25M-164.29M-159.77M-155.76M-151.55M-145.84M-141.66M-137.11M-131.92M
Treasury Stock----------
Other Liabilities----0.01M-0.02M-0.01M-0.01M-0.01M-0.03M-0.11M
Shareholders Equity-8M10.66M14.76M18.37M22.19M27.51M31.28M35.47M40.22M
Total Liabilities & Shareholders Equity22.6M16.57M18.97M48.43M52.64M56.57M61.58M65.7M70.1M74.24M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at Arcadia Biosciences historical stock prices and the current Arcadia Biosciences stock price can tell you how the stock price has moved, whereas the Arcadia Biosciences PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: RKDA total assets, which was at $22.6M for 2018 Q1 is a balance sheet item representing value of what Arcadia Biosciences owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: The total liabilities of Arcadia Biosciences for the quarter 2018 Q1 total to $21.93M. Liabilities for a company like Arcadia Biosciences include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Arcadia Biosciences Balance Sheet - Key Ratios

Current ratio
7.01
Debt to equity ratio
0
Asset turnover ratio
0.04
Receivables turnover
6.65
Price to book ratio
2.08